Key results from December 2016

December ended with the following results:

  • we successfully completed the end of year review for the portfolio companies. ¬†Overall, the revenue for the portfolio grew by over 80% year-on-year
  • we maintained 100% survival rate for portfolio for the year
  • we successfully funded¬†all portfolio companies looking for capital (from our network of early stage investors)